Showing results (601-610 of 653) with videos related to
Sort By:
Pageof 66
The Journal of Pediatrics|January 11, 2016
Neurodevelopmental Outcome and Treatment Efficacy of Benzoate and Dextromethorphan in Siblings with Attenuated Nonketotic HyperglycinemiaKendra J Bjoraker, Michael A Swanson, Curtis R Coughlin, et al.Nature Immunology|December 20, 2016
A gene network regulated by the transcription factor VGLL3 as a promoter of sex-biased autoimmune diseasesYun Liang, Lam C Tsoi, Xianying Xing, et al.Translational Oncology|April 29, 2014
Phase II Trial of Cetuximab and Conformal Radiotherapy Only in Locally Advanced Pancreatic Cancer with Concurrent Tissue Sampling Feasibility StudyAgata I Rembielak, Pooja Jain, Andrew S Jackson, et al.The British Journal of Dermatology|November 18, 2023
Formylpeptide receptor 1 contributes to epidermal barrier dysfunction-induced skin inflammation through NOD-like receptor C4-dependent keratinocyte activationShuai Shao, Zhongbin Sun, Mengyang Chu, et al.Journal of Clinical Medicine|July 12, 2025
V-CARE (Virtual Care After REsuscitation): Protocol for a Randomized Feasibility Study of a Virtual Psychoeducational Intervention After Cardiac Arrest-A STEPCARE Sub-StudyMarco Mion, Gisela Lilja, Mattias Bohm, et al.Annals of Neurology|July 17, 2015
Biochemical and molecular predictors for prognosis in nonketotic hyperglycinemiaMichael A Swanson, Curtis R Coughlin, Gunter H Scharer, et al.Plos One|April 13, 2011
Genome-wide expression profiling of five mouse models identifies similarities and differences with human psoriasisWilliam R Swindell, Andrew Johnston, Steve Carbajal, et al.Journal of Medical Genetics|March 20, 2015
Mutations in the mitochondrial cysteinyl-tRNA synthase gene, CARS2, lead to a severe epileptic encephalopathy and complex movement disorderCurtis R Coughlin, Gunter H Scharer, Marisa W Friederich, et al.ACS Nano|January 14, 2026
Atomic Imaging of 2D Transition Metal DiiodidesWendong Wang, Gareth R Tainton, Nicholas J Clark, et al.Science Translational Medicine|August 22, 2014
IL-32 is a molecular marker of a host defense network in human tuberculosisDennis Montoya, Megan S Inkeles, Phillip T Liu, et al.Pageof 66